Pfizer’s Colorectal Cancer Drug Achieves Dual Primary Goals in Pivotal Clinical Trial: A New Milestone in Cancer Treatment

marketsgonewild05 mins

Pfizer’s Braftovi Combo Regimen Shows Promise in Late-Stage BRAF V600E-mutant mCRC Study In a recent development, Pfizer announced that its late-stage study of the Braftovi (encorafenib) and MEKTOVI (binimetinib) combination regimen for the treatment of BRAF V600E-mutant metastatic colorectal cancer (mCRC) has met its second primary endpoint of Progression-free Survival (PFS) with statistical significance. This…

Read More

Iconic Announces Cancellation of Option Agreement for New Pass Gold Project: What This Means for Shareholders

marketinsider06 mins

Iconic Minerals Ltd. Terminates Option Agreement with Gold Basin Resources Corporation Vancouver, British Columbia – Iconic Minerals Ltd. (TSXV: ICM) (OTC: ICMFF) (FSE: YQG) (the “Company” or “Iconic”) is pleased to announce that it has mutually agreed to terminate the property option agreement (the “Option Agreement”) with Gold Basin Resources Corporation (TSXV: GXX) (OTCQB: GXXFF)…

Read More

“Unlocking the Secret to Earning $10,000 with XRP or Solana: A Foolproof Guide for the Savvy Investor”

ilikefinance06 mins

XRP vs. Solana: The Battle of Cryptocurrencies Introduction So, you’ve heard about XRP and Solana, and you’re intrigued by the potential of these cryptocurrencies to make you a boatload of money. You’ve seen the headlines about people becoming millionaires overnight from investing in these digital assets. But is it really that easy? Can you turn…

Read More